NUGT News 32.78 09/17/2014 05:32:52 Gold Miners Bull 3X Direxion

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gold Miners Bull 3X Direxion (NUGT) 32.78 $NUGT

Downtrend Call Working As Direxion Daily Gold Miners Bull 2x Shares Stock Falls 24.9% (NUGT)
Comtex SmarTrend(R) - Mon Sep 15, 10:57AM CDT
SmarTrend identified a Downtrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on August 22nd, 2014 at $42.87. In approximately 3 weeks, Direxion Daily Gold Miners Bull 2x Shares has returned 24.93% as of today's recent price of $32.18.

Shares of NUGT Now Oversold
ETFChannel.com - Wed Sep 10, 3:15PM CDT
In trading on Wednesday, shares of the Daily Gold Miners Bull 3x Shares ETF entered into oversold territory, changing hands as low as $32.76 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical...

Direxion Daily Gold Miners Bull 2x Shares Falls 10.02% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Sep 08, 4:22PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $33.64 to a high of $37.01. Yesterday, the shares fell 10.0%, which took the trading range below the 3-day low of $35.96 on volume of 6.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Downtrend Call Working As Direxion Daily Gold Miners Bull 2x Shares Stock Falls 15.5% (NUGT)
Comtex SmarTrend(R) - Mon Sep 08, 9:38AM CDT
SmarTrend identified a Downtrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on August 22nd, 2014 at $42.87. In approximately 2 weeks, Direxion Daily Gold Miners Bull 2x Shares has returned 15.53% as of today's recent price of $36.21.

Watch for Direxion Daily Gold Miners Bull 2x Shares to Potentially Rebound After Falling 9.73% Yesterday
Comtex SmarTrend(R) - Tue Sep 02, 5:15PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $41.20 to a high of $43.35. Yesterday, the shares fell 9.7%, which took the trading range below the 3-day low of $42.80 on volume of 4.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Pullback in Shares of Direxion Daily Gold Miners Bull 2x Shares After 2.33% Gain
Comtex SmarTrend(R) - Fri Aug 29, 4:03PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $43.93 to a high of $46.09. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $44.85 on volume of 2.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Decline of 5.07%, Direxion Daily Gold Miners Bull 2x Shares Offers Investors Better Value
Comtex SmarTrend(R) - Mon Aug 25, 4:40PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $40.75 to a high of $42.78. Yesterday, the shares fell 5.1%, which took the trading range below the 3-day low of $42.01 on volume of 3.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 6.54%, Direxion Daily Gold Miners Bull 2x Shares Offers Investors Better Value
Comtex SmarTrend(R) - Thu Aug 21, 3:52PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $42.30 to a high of $44.45. Yesterday, the shares fell 6.5%, which took the trading range below the 3-day low of $45.50 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Direxion Daily Gold Miners Bull 2x Shares Has Returned 29.5% Since SmarTrend Recommendation (NUGT)
Comtex SmarTrend(R) - Wed Aug 20, 4:47PM CDT
SmarTrend identified an Uptrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on June 16th, 2014 at $35.55. In approximately 2 months, Direxion Daily Gold Miners Bull 2x Shares has returned 29.54% as of today's recent price of $46.05.

Uptrend Call Working As Direxion Daily Gold Miners Bull 2x Shares Stock Rises 42.1% (NUGT)
Comtex SmarTrend(R) - Wed Aug 13, 10:58AM CDT
SmarTrend identified an Uptrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on June 16th, 2014 at $35.55. In approximately 2 months, Direxion Daily Gold Miners Bull 2x Shares has returned 42.05% as of today's recent price of $50.50.

Direxion Daily Gold Miners Bull 2x Shares Shares Up 28.3% Since SmarTrend's Buy Recommendation (NUGT)
Comtex SmarTrend(R) - Wed Aug 06, 9:43AM CDT
SmarTrend identified an Uptrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on June 16th, 2014 at $35.55. In approximately 2 months, Direxion Daily Gold Miners Bull 2x Shares has returned 28.27% as of today's recent price of $45.60.

SmarTrend Watching for Potential Rebound in Shares of Direxion Daily Gold Miners Bull 2x Shares After 2.69% Loss
Comtex SmarTrend(R) - Mon Aug 04, 4:09PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $41.57 to a high of $44.20. Yesterday, the shares fell 2.7%, which took the trading range below the 3-day low of $42.20 on volume of 3.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Direxion Daily Gold Miners Bull 2x Shares Up 27.8% Since SmarTrend Uptrend Call (NUGT)
Comtex SmarTrend(R) - Wed Jul 30, 9:11AM CDT
SmarTrend identified an Uptrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on June 16th, 2014 at $35.55. In approximately 1 month, Direxion Daily Gold Miners Bull 2x Shares has returned 27.85% as of today's recent price of $45.45.

Look for Shares of Direxion Daily Gold Miners Bull 2x Shares to Potentially Pullback after Yesterday's 1.80% Rise
Comtex SmarTrend(R) - Mon Jul 28, 5:05PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $45.91 to a high of $48.11. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $47.58 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Direxion Daily Gold Miners Bull 2x Shares to Potentially Rebound after Yesterday's 4.75% Sell Off
Comtex SmarTrend(R) - Thu Jul 24, 4:36PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $42.89 to a high of $44.86. Yesterday, the shares fell 4.7%, which took the trading range below the 3-day low of $45.60 on volume of 2.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Shares of NUGT Up 30.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jul 22, 4:43PM CDT
SmarTrend identified an Uptrend for Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) on June 16th, 2014 at $35.55. In approximately 1 month, Direxion Daily Gold Miners Bull 2x Shares has returned 30.24% as of today's recent price of $46.30.

Watch for Direxion Daily Gold Miners Bull 2x Shares to Potentially Pullback After Gaining 8.09% Yesterday
Comtex SmarTrend(R) - Thu Jul 17, 5:03PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $45.03 to a high of $48.67. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of $48.37 on volume of 5.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Rebound in Shares of Direxion Daily Gold Miners Bull 2x Shares After 7.82% Loss
Comtex SmarTrend(R) - Mon Jul 14, 4:14PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $45.64 to a high of $48.37. Yesterday, the shares fell 7.8%, which took the trading range below the 3-day low of $46.75 on volume of 4.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of Direxion Daily Gold Miners Bull 2x Shares to Potentially Pullback after Yesterday's 7.64% Rise
Comtex SmarTrend(R) - Wed Jul 09, 3:52PM CDT
Direxion Daily Gold Miners Bull 2x Shares (NYSE:NUGT) traded in a range yesterday that spanned from a low of $46.87 to a high of $50.22. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high of $46.40 on volume of 5.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading